Lapatinib Terminated Phase 2 Trials for Metastatic Bladder Cancer / Recurrent Bladder Cancer / Stage III Bladder Cancer / Transitional Cell Carcinoma of the Bladder Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01382706Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder